Anuh Pharma Ltd Stock Analysis

BSE: 506260 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price 07-Dec-2022 18:17
92.00 -1.40 (-1.50%)

DeciZen - Make an Informed Decision on Anuh Pharma

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation


3. Price Trend

Anuh Pharma Price Chart

P/E Ratio (SA) :
Market Cap :
468.1 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Anuh Pharma Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Anuh Pharma Ltd is a average quality company.

2. Is Anuh Pharma Ltd undervalued or overvalued?

The key valuation ratios of Anuh Pharma Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Anuh Pharma Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Anuh Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Anuh Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Anuh Pharma Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 20.1%24.7%24.6%25.3%15.2%10.7%16%10.3%12.1%15.1%-
Value Creation Index

Growth Parameters

Growth Parameters Colour Code Guide

Sales 243266284326206238321307432487492
YoY Gr. Rt. %-9.8%6.5%15%-36.8%15.5%34.7%-4.3%40.7%12.7%-
YoY Gr. Rt. %-36.4%16.8%22.9%-29.4%-20.7%64.2%-27%26.9%31.3%-
BVPS (₹)
Adj Net Profit
Cash Flow from Ops. 1.614.618.816.526.
Debt/CF from Ops. 0.3000.


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8%18.7%14.9%12.7%
Adj EPS 9.1%9.6%6.7%31.3%
Share Price 13.8% 0.5% 12.2% -13.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 19.423.723.92514.910.616.111.313.315.215.4
Op. Profit Mgn % 8.310.511.912.3118.610.81010.510.110.3
Net Profit Mgn %
Debt to Equity 00000000.30.100
Working Cap Days 111127127116176153139169153162194
Cash Conv. Cycle 29262933586254473250105

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 15.40%

Sales growth is growing at healthy rate in last 3 years 14.92%

Sales growth is good in last 4 quarters at 17.93%

Net Profit has been subdued in last 3 years 6.74%

Latest Financials - Anuh Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 6.7 -
TTM Sales (₹ Cr.) 492 -
BVPS (₹.) 44.3 -
Reserves (₹ Cr.) 197 -
P/BV 2.11 -
PE 13.92 -
From the Market
52 Week Low / High (₹) 82.50 / 129.45
All Time Low / High (₹) 0.03 / 218.70
Market Cap (₹ Cr.) 468
Equity (₹ Cr.) 25.1
Face Value (₹) 5
Industry PE 37.5

Management X-Ray of Anuh Pharma :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Anuh Pharma

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Anuh Pharma Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Anuh Pharma on 07-Dec-2022 18:17 is : 92.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 07-Dec-2022 18:17 the market cap of Anuh Pharma stood at ₹ 468.1.
The latest PE ratio of Anuh Pharma as of 07-Dec-2022 18:17 is 13.92.
The latest PB ratio of Anuh Pharma as of 07-Dec-2022 18:17 is 2.11
The 52-week high of Anuh Pharma is ₹ 129.4 and the 52-week low is ₹ 82.50.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Anuh Pharma is ₹ 492.1 ( Cr.) .

About Anuh Pharma Ltd

Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

The company has grown several immensely and earned recognition, besides gaining the trust of a strong customer base. Today, it is one of the largest producers of macrolides in the country.

Anuh Pharma has a product presence in Africa, Asia, Europe, Central/South America and the Middle East. The company's registered office is at E-17/3 and 17/4 MIDC, Tarapur, Boisar, Thane District 401506


  • Macrolides
  • Higher Macrolides
  • Quinolones
  • Chloramphenicol
  • Anti TB Drug
  • Corticosteroids


  • Anuh Pharma has received ‘Star Export House’ certification from the Ministry of Commerce and Industry.
  • The company received WHO-GMP certificate for carrying good manufacturing practices.
  • Anuh Pharma has received  ISO 9001:2000 certification
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now